Hypertension

Featured Article

Considering Sodium Intake in Hypertension Prevention: Worth Its Salt?

Considering Sodium Intake in Hypertension Prevention: Worth Its Salt?

A recent investigation found that very low sodium intake may actually increase the risk for CVD and mortality.

Latest News

FDA Approves First Sodium Nitroprusside For Hypertension

FDA Approves First Sodium Nitroprusside For Hypertension

The injection is the first ready-to-use sodium nitroprusside intended for immediate blood pressure reduction.

Adherence to Therapy for Resistant Hypertension Lacking

Adherence to Therapy for Resistant Hypertension Lacking

Nonadherence to hypertension therapy leads to increased costs and patient risks.

Quarter-Dose Combination Antihypertensive Therapy Highly Effective

Quarter-Dose Combination Antihypertensive Therapy Highly Effective

A mean difference of 18.7 mm Hg in 24-hour systolic blood pressure was observed in patients given the antihypertensive "quadpill."

Effects of Intensive Blood Pressure Lowering Therapy on Gait and Mobility

Effects of Intensive Blood Pressure Lowering Therapy on Gait and Mobility

Intensive blood pressure-lowering therapy (systolic blood pressure <120 mm Hg) was not associated with changes in gait speed or mobility in older adults.

Does Blood Pressure Management Lower Cardiovascular Risk in Diabetes?

Does Blood Pressure Management Lower Cardiovascular Risk in Diabetes?

Researchers analyzed the effects of lowered blood pressure in patients with and without diabetes.

Blood Pressure Trajectories in Childhood Predict CVD Risk

Blood Pressure Trajectories in Childhood Predict CVD Risk

Patients with higher blood pressure trajectories also had thicker carotid intima-media thickness and increased LV mass index.

Rising Systolic Blood Pressure Rates Are a Global Concern

Rising Systolic Blood Pressure Rates Are a Global Concern

Systolic blood pressure rates are on the rise, which could lead to increased incidences of ischemic heart disease, cerebrovascular disease, and chronic kidney disease.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Initial combination therapy with ambrisentan and tadalafil reduced the risk for first clinical failure event in patients with connective tissue disease-associated pulmonary arterial hypertension.

Masked Hypertension Prevalence in the United States

Masked Hypertension Prevalence in the United States

As many as 17.1 million Americans may have masked hypertension.

Does Low-Dose Diuretic Therapy Reduce Hypertension Risk?

Does Low-Dose Diuretic Therapy Reduce Hypertension Risk?

Low-dose chlorthalidone/amiloride reduced hypertension and left ventricular mass.

Sign Up for Free e-Newsletters